Co-treatment with the anti-malarial drugs mefloquine and primaquine highly sensitizes drug-resistant cancer cells by increasing P-gp inhibition.
about
Maytansine-loaded star-shaped folate-core PLA-TPGS nanoparticles enhancing anticancer activityThioridazine specifically sensitizes drug-resistant cancer cells through highly increase in apoptosis and P-gp inhibition.Lysosomotropism depends on glucose: a chloroquine resistance mechanismTherapeutic effects of antibiotic drug mefloquine against cervical cancer through impairing mitochondrial function and inhibiting mTOR pathway.Adverse neuropsychiatric effects of antimalarial drugs.Inhibition of glioblastoma cell proliferation, invasion, and mechanism of action of a novel hydroxamic acid hybrid molecule
P2860
Co-treatment with the anti-malarial drugs mefloquine and primaquine highly sensitizes drug-resistant cancer cells by increasing P-gp inhibition.
description
2013 nî lūn-bûn
@nan
2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Co-treatment with the anti-mal ...... by increasing P-gp inhibition.
@ast
Co-treatment with the anti-mal ...... by increasing P-gp inhibition.
@en
type
label
Co-treatment with the anti-mal ...... by increasing P-gp inhibition.
@ast
Co-treatment with the anti-mal ...... by increasing P-gp inhibition.
@en
prefLabel
Co-treatment with the anti-mal ...... by increasing P-gp inhibition.
@ast
Co-treatment with the anti-mal ...... by increasing P-gp inhibition.
@en
P2093
P1476
Co-treatment with the anti-mal ...... by increasing P-gp inhibition.
@en
P2093
Ae-Ran Choi
Ju-Hwa Kim
Sungpil Yoon
Yong Kee Kim
P304
P356
10.1016/J.BBRC.2013.10.095
P407
P577
2013-10-26T00:00:00Z